Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Gains from Investment Securities: 2011-2025

Historic Gains from Investment Securities for Innoviva (INVA) over the last 12 years, with Sep 2025 value amounting to $1.1 million.

  • Innoviva's Gains from Investment Securities fell 90.44% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year increase of 95.53%. This contributed to the annual value of $11.8 million for FY2024, which is 2181.04% up from last year.
  • Per Innoviva's latest filing, its Gains from Investment Securities stood at $1.1 million for Q3 2025, which was down 91.16% from $12.7 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Gains from Investment Securities peaked at $112.6 million during Q1 2021, and registered a low of -$3.1 million during Q2 2023.
  • Its 3-year average for Gains from Investment Securities is $2.7 million, with a median of $1.1 million in 2025.
  • As far as peak fluctuations go, Innoviva's Gains from Investment Securities surged by 204,603.64% in 2021, and later crashed by 152.81% in 2025.
  • Over the past 5 years, Innoviva's Gains from Investment Securities (Quarterly) stood at $30.0 million in 2021, then crashed by 60.03% to $45.0 million in 2022, then tumbled by 95.42% to $770,000 in 2023, then surged by 1,431.56% to $11.8 million in 2024, then plummeted by 90.44% to $1.1 million in 2025.
  • Its Gains from Investment Securities stands at $1.1 million for Q3 2025, versus $12.7 million for Q2 2025 and -$799,000 for Q1 2025.